Related Experiment Video
Updated: Aug 29, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP
Matthias Pauschinger1, Kumaran Chandrasekharan, Heinz-Peter Schultheiss
1Department of Cardiology, University Hospital Benjamin Franklin, Free University Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany. pauschinger@ukbf.fu-berlin.de
Abstract:
Matrix metalloproteinases (MMP), a family of proteases, are involved in the degradation of extracellular matrix proteins and hence in the determination of interstitial architecture. In the heart, MMPs have been found to play a significant role in the development of myocardial remodeling and congestive heart failure. Tissue inhibitors of matrix metalloproteinases (TIMPs) represent a family of proteins which are known to regulate the expression and activity of MMPs. TIMPs are endogenous physiological inhibitors of MMPs and their concomitant downregulation in heart failure suggests the existence of a critical balance between MMPs and TIMPs in the normal maintenance of myocardial interstitial homeostasis. In addition, cytokines regulate expression of both MMPs and TIMPs besides eliciting a direct effect on myocardial cell function. Therefore, myocardial inflammation may also contribute to the development of cardiac remodeling along with other stimuli like mechanical stress and humoral factors. Viral myocarditis, a predisposing factor for dilated cardiomyopathy, is a condition in which extent of intramyocardial inflammation is thought to determine the progression of disease. Inflammatory events in the heart following viral infection are speculated to be responsible for the transition of myocarditis to dilated cardiomyopathy. In viral myocarditis and other inflammatory heart diseases, the inflammatory cells and their battery of cytokines may also alter the myocardial MMP-TIMP system and eventually lead to dilation of the heart and ventricular dysfunction. The objective of this review is to present an overall picture of the inflammatory phase in viral myocarditis and discuss the possible interactions between inflammation and myocardial MMP profiles which may lead to the evolution of dilated cardiomyopathy.
Insights
Inflammation in viral myocarditis alters the balance of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). This imbalance contributes to cardiac remodeling and the progression to dilated cardiomyopathy.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Pathophysiology
Background:
- Matrix metalloproteinases (MMPs) degrade extracellular matrix, influencing cardiac interstitial architecture.
- MMPs and their inhibitors (TIMPs) are crucial for maintaining myocardial homeostasis; their imbalance is implicated in heart failure.
- Cytokines and inflammation, particularly in viral myocarditis, can disrupt the MMP-TIMP system and contribute to cardiac remodeling.
Purpose of the Study:
- To review the inflammatory phase in viral myocarditis.
- To explore the interplay between inflammation and myocardial MMP profiles.
- To elucidate the mechanisms leading to dilated cardiomyopathy.
Main Methods:
- Literature review of viral myocarditis and cardiac remodeling.
- Analysis of the role of MMPs and TIMPs in myocardial inflammation.
- Examination of cytokine-mediated effects on the MMP-TIMP system.
Main Results:
- Viral infections trigger intramyocardial inflammation, a key factor in disease progression.
- Inflammatory cells and cytokines in viral myocarditis can dysregulate the myocardial MMP-TIMP system.
- Alterations in the MMP-TIMP system are linked to cardiac dilation and ventricular dysfunction.
Conclusions:
- Inflammation is a critical determinant in the progression of viral myocarditis to dilated cardiomyopathy.
- The MMP-TIMP system is a key mediator linking inflammation to cardiac remodeling.
- Understanding these interactions may reveal therapeutic targets for preventing dilated cardiomyopathy.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
